These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 136072)

  • 1. Inability of normal and activated thymus-derived cells to act as cytotoxic effector cells against antibody-coated targets.
    Forman J; Britton S; Möller G
    Transplantation; 1976 Oct; 22(4):374-9. PubMed ID: 136072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells.
    Forman J; Möller G
    J Exp Med; 1973 Sep; 138(3):672-85. PubMed ID: 4269560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
    Waterfield JD; Waterfield EM; Möller G
    Cell Immunol; 1975 Jun; 17(2):392-404. PubMed ID: 805001
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):317-20. PubMed ID: 136357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fc receptor on thymus-derived lymphocytes: II. Mitogen responsiveness of T lymphocytes bearing the Fc receptor.
    Stout RD; Herzenberg LA
    J Exp Med; 1975 Nov; 142(5):1041-51. PubMed ID: 1081574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of the Fc receptor on mixed lymphocyte culture-activated T blasts.
    Hayry P; Andersson LC
    Cell Immunol; 1976 Aug; 25(2):237-44. PubMed ID: 133765
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
    Forman J; Britton S
    J Exp Med; 1973 Feb; 137(2):369-86. PubMed ID: 4539847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 12. Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes.
    Krammer PH; Hudson L; Sprent J
    J Exp Med; 1975 Dec; 142(6):1403-15. PubMed ID: 1081578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):309-16. PubMed ID: 1086781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some characteristics of the antibody-induced cell-mediated cytotoxicity against leukemia cells.
    Britton S; Forman J
    Transplantation; 1974 Feb; 17(2):180-7. PubMed ID: 4590289
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in the mitogen responsiveness of lymphocytes from mice bearing Moloney sarcoma virus induced tumors.
    Marshall GD; Thurman GB; Foster BG; Goldstein A
    Immunol Commun; 1977; 6(6):603-15. PubMed ID: 304835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
    Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
    Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity.
    Kirchner H; Blaese RM
    J Exp Med; 1973 Oct; 138(4):812-24. PubMed ID: 4542736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity.
    Galili U; Schlesinger M
    J Immunol; 1975 Sep; 115(3):827-33. PubMed ID: 125304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.